Swedish Medical Center, a 408-bed acute care hospital in Englewood, announced plans to build a new cancer treatment center intended to open by the end of 2022.
The hospital has been doing pre-construction work since April, according to hospital spokesperson Alyssa Parker, with construction expected to begin in January.
“This effort brings together all of the components we have already built in our fight against cancer into a singular, dedicated space,” said Ryan Tobin, president and chief executive officer of Swedish Medical Center, in a news release.
The new facility, dubbed a “cancer pavilion,” is set to centralize the various oncology services of the hospital's Sarah Cannon Cancer Institute by connecting two of its East Hampden Avenue medical office buildings.
The project is estimated to cost $25 million, with the hospital securing funding from various partners including HCA Healthcare and Sarah Cannon as well as from its facility operating budget, according to Parker.
The new space will house oncology physician offices and comprehensive patient support services as well as a new grand entryway, redesigned landscaping and outdoor spaces for patients.
“In addition to making care more convenient, we want to make our space healing,” Tobin said in his statement. “We understand that cancer treatment can be stressful and frightening. We are taking every possible measure to create a peaceful, serene environment for our patients.”
The hospital serves about 2,000 cancer patients each year, according to Parker, with Sarah Cannon providing services since 2012. Parker, in an email to Colorado Community Media, said the new space could allow the hospital to care for even more patients.
“While some of the project involves reconfiguring existing services, we expect the streamlined approach to enrich the patient experience, enhance provider satisfaction, and ultimately expand the number of patients for which we can provide care,” she said.
Other items that may interest you
We have noticed you are using an ad blocking plugin in your browser.
The revenue we receive from our advertisers helps make this site possible. We request you whitelist our site.